Chemotherapy-Induced Peripheral Neuropathy (CIPN) Prevention: 3 RCTs (n=437, n=160, n=150) found no prophylactic benefit of acetyl-L-carnitine
Together, theyre like a dynamic duo for maintaining weight loss after GLP-1
GLP-1 Insurance Coverage Statistics 2026 | Employer, Medicare & Medicaid Data GLP-1 Insurance Coverage Statistics 2026: Employer Plans, Medicare & Medicaid Data The most current data on who actually pays for GLP-1 weight loss medications in 2026
EFSA caffeine opinion summary Food Standards Agency
In one 2010 study, funded by Supresa patent holder Inoreal Ltd, 30 slightly overweight women were given a saffron supplement daily for eight weeks, and 30 others received a placebo
583 Similarly, siZIP4 evoked an epithelioid phenotype in NSCLC, reduced the expression of CSC markers, and elevated cisplatin sensitivity